Difficulty: Medium
Average Score: 68%
Practice
A 55-year-old man with congestive heart failure is noted to be taking furosemide each day. Which of the following is most likely to be found in the serum?
Correct answer
A
Rationale
In this scenario, the correct answer is option A) Decreased potassium level. Furosemide is a loop diuretic commonly used in congestive heart failure to reduce fluid overload. One of its primary side effects is the loss of potassium through increased urine output. This loss of potassium can lead to hypokalemia, which may manifest as weakness, muscle cramps, and cardiac arrhythmias.
Option B) Decreased blood sugar level is incorrect because furosemide does not directly affect blood sugar levels. Option C) Elevated magnesium level is incorrect as furosemide is more likely to cause magnesium wasting due to its mechanism of action. Lastly, option D) Low bicarbonate level is incorrect because furosemide is not known to directly impact bicarbonate levels in the serum.
Educationally, understanding the side effects of medications is crucial for healthcare professionals to provide safe and effective care. In this case, knowing that furosemide can lead to hypokalemia informs clinicians to monitor and supplement potassium levels in patients taking this medication, especially those with underlying conditions like congestive heart failure. This knowledge helps in preventing potential complications related to electrolyte imbalances.
Option B) Decreased blood sugar level is incorrect because furosemide does not directly affect blood sugar levels. Option C) Elevated magnesium level is incorrect as furosemide is more likely to cause magnesium wasting due to its mechanism of action. Lastly, option D) Low bicarbonate level is incorrect because furosemide is not known to directly impact bicarbonate levels in the serum.
Educationally, understanding the side effects of medications is crucial for healthcare professionals to provide safe and effective care. In this case, knowing that furosemide can lead to hypokalemia informs clinicians to monitor and supplement potassium levels in patients taking this medication, especially those with underlying conditions like congestive heart failure. This knowledge helps in preventing potential complications related to electrolyte imbalances.